The Glaucoma Treatment Spectrum: Meds, Sustained Delivery, and MIGS
CME Activity Pricing
ASCRS Member Price: FREE
Nonmember Price: FREE
ASCRS gratefully acknowledges the unrestricted educational grants received in support of this program from AbbVie, Glaukos, Mati Therapeutics, and Sight Sciences.
This new program will discuss principles for adjusting and optimizing phaco machine settings for both routine and complex cases. Special attention will be given to surgical strategies for rock hard cataracts and complicated cases.
Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.
Duration: 60 minutes
Activity Expiration Date: December 31, 2023
|Leon W. Herndon, MD||Nathan Radcliffe, MD|
|Jacob Brubaker. MD||Sahar Bedrood, MD||Won Kim, MD||Thomas Patrianakos, DO|
Ophthalmologists attending this program should be able to:
- Compare and contrast the various MIGS approaches now and in the pipeline for Glaucoma treatment.
- Describe new and emerging options in glaucoma medical therapy.